MinervaX reveals financing to development group B streptococcus vaccine

Plans include phase 3 clinical development of novel GBS vaccine and an efficacy evaluation - News - PharmaTimes

Related Keywords

South Africa ,Wellington ,New Zealand General ,New Zealand ,Denmark ,United Kingdom ,Veronica Gambillara ,Pureos Bioventures ,European Medicines Agency ,Impact Fund ,European Investment Bank ,Trill Impact Ventures ,Sanofi Ventures ,Sunstone Life Science Ventures ,Wellington Partners ,Adjuvant Capital ,Minervax ,Accine ,Trepococcus ,